Literature DB >> 15824877

[Cardiac resynchronization therapy--what will the future bring?].

C Stellbrink1.   

Abstract

Mesh：

Year:  2005        PMID： 15824877     DOI： 10.1007/s00399-005-0456-y

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN： 0938-7412


× No keyword cloud information.
  23 in total

1.  Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling.

Authors:  Leslie A Saxon; Teresa De Marco; Jill Schafer; Kanu Chatterjee; Uday N Kumar; Elyse Foster
Journal:  Circulation       Date:  2002-03-19       Impact factor: 29.690

2.  Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation.

Authors:  C Leclercq; S Walker; C Linde; J Clementy; A J Marshall; P Ritter; P Djiane; P Mabo; T Levy; F Gadler; C Bailleul; J-C Daubert
Journal:  Eur Heart J       Date:  2002-11       Impact factor: 29.983

3.  Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function.

Authors:  P F Bakker; H W Meijburg; J W de Vries; M M Mower; A C Thomas; M L Hull; E O Robles De Medina; J J Bredée
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

4.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

5.  Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

Authors:  William T Abraham; James B Young; Angel R León; Stuart Adler; Alan J Bank; Shelley A Hall; Randy Lieberman; L Bing Liem; John B O'Connell; John S Schroeder; Kevin R Wheelan
Journal:  Circulation       Date:  2004-10-25       Impact factor: 29.690

6.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

7.  Multisite pacing for end-stage heart failure: early experience.

Authors:  S Cazeau; P Ritter; A Lazarus; D Gras; H Backdach; O Mundler; J Mugica
Journal:  Pacing Clin Electrophysiol       Date:  1996-11       Impact factor: 1.976

8.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R Kleiger; J P Miller; L M Rolnitzky
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

9.  Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block.

Authors:  Christophe Leclercq; Owen Faris; Richard Tunin; Jennifer Johnson; Ritsuchi Kato; Frank Evans; Julio Spinelli; Henry Halperin; Elliot McVeigh; David A Kass
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

10.  Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

Authors:  M St John Sutton; M A Pfeffer; T Plappert; J L Rouleau; L A Moyé; G R Dagenais; G A Lamas; M Klein; B Sussex; S Goldman
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.